[Prevalence of cardiovascular risk factors in Balearic workers apparently healthy]. by López-González, A, Angullo Martínez, E, Román Rodríguez, M, Vicente-Herrero, M, Tomás Salvá, M, Ricci-Cabello, I

“… BACKGROUND: the prevalence of cardiovascular risk factors is well known in the general population. …”

[Computed tomographic measurement of coronary artery calcification in the assessment of cardiovascular risk: a descriptive study]. by Morcillo, C, Valderas, J, Roca, J, Oliveró, R, Núñez, C, Sánchez, M, Bechich, S

“… INTRODUCTION AND OBJECTIVES: Measurement of coronary artery calcification (CAC) is used in the evaluation of cardiovascular risk. We investigated its usefulness by comparing CAC assessment with that of various risk charts. …”

Do inhaled anticholinergics increase the risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease? by Prieto Alhambra, D, Don, M, Galán Aisa, A, Castillo, D, Martín Cantera, C

[Expert consensus document on the use of antiplatelet agents]. by Patrono, C, Bachmann, F, Baigent, C, Bode, C, De Caterina, R, Charbonnier, B, Fitzgerald, D, Hirsh, J, Husted, S, Kvasnicka, J, Montalescot, G, García Rodríguez, L, Verheugt, F, Vermylen, J, Wallentin, L, Grupo de Trabajo sobre el uso de agentes antiplaquetarios en pacientes con enfermedad cardiovascular aterosclerótica de la Sociedad Europea de Cardiología

Validity for use in research on vascular diseases of the SIDIAP (Information System for the Development of Research in Primary Care): The EMMA study by Ramos, R, Balló, E, Marrugat, J, Elosua, R, Sala, J, Grau, M, Vila, J, Bolíbar, B, García-Gil, M, Martí, R, Fina, F, Hermosilla, E, Rosell, M, Muñoz, M, Prieto-Alhambra, D, Quesada, M

“…Methods: We compared the prevalence of cardiovascular risk factors observed in EMMA-hypertension, diabetes, hypercholesterolemia (and its treatments), obesity, and smoking-with equivalent data from the Registre Gironí del Cor (REGICOR), a population-based study that uses standardized methodology, in 2000. …”

Optimizing observer performance of clinic blood Pressure measurement: a position statement from the Lancet Commission on Hypertension Group [Otimização do desempenho do observador... by Padwal, R, Campbell, NRC, Schutte, AE, Olsen, MH, Delles, C, Etyang, A, Cruickshank, JK, Etyong, A, Stergiou, G, Rakotz, MK, Wozniak, G, Jaffe, MG, Benjamin, I, Parati, G, Sharman, JE

“…High blood pressure (BP) is a highly prevalent modifiable cause of cardiovascular disease, stroke, and death. Accurate BP measurement is critical, given that a 5-mmHg measurement error may lead to incorrect hypertension status classification in 84 million individuals worldwide. …”